J Inherit Metab Dis 45:192202
(Boca Raton, FL: CRC Press), 4788
The weight loss trajectory with retatrutide is steeper and more prolonged than those reported for tirzepatide and semaglutide in cross-trial comparisons
The structural valve failure that causes varicose veins, spider veins, and chronic venous insufficiency does not reverse with weight loss alone, and GLP-1 medications are not a substitute for vein treatment
Tirzepatide (15mg) is a dual GIP and GLP-1 receptor agonist studied for its impact on type 2 diabetes and obesity
OnlineSemaglutide.org is the only provider here that publicly names all four of its partner compounding pharmacies (Belmar, Strive, Epiq Scripts, and Casa Pharma Rx) and lists three NPI-verifiable prescribers on its About page